Advertisement

Topics

Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update

16:09 EST 25 Feb 2019 | Biotech 365

MENLO PARK, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stressContinue reading

Original Article: Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update

NEXT ARTICLE

More From BioPortfolio on "Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...